TD Asset Management
TAK icon

TD Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

TD Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,760
Closed -$782K – 1546
2021
Q3 		$782K Sell
47,760
-265
-0.6% -$4.45K ﹤0.01% 1309
2021
Q2 		$792K Sell
48,025
-931
-2% -$15.8K ﹤0.01% 1305
2021
Q1 		$894K Sell
48,956
-3,616
-7% -$65.1K ﹤0.01% 1282
2020
Q4 		$957K Buy
52,572
+2,001
+4% +$35.1K ﹤0.01% 1197
2020
Q3 		$902K Sell
50,571
-596,993
-92% -$10.9M ﹤0.01% 1102
2020
Q2 		$11.6M Sell
647,564
-56,288
-8% -$1.01M 0.02% 482
2020
Q1 		$10.7M Sell
703,852
-24,123
-3% -$437K 0.02% 453
2019
Q4 		$14.4M Buy
727,975
+80,950
+13% +$1.55M 0.02% 454
2019
Q3 		$11.1M Buy
647,025
+115,932
+22% +$2.01M 0.02% 492
2019
Q2 		$9.4M Sell
531,093
-66,507
-11% -$1.21M 0.01% 542
2019
Q1 		$12.2M Buy
597,600
+470,705
+371% +$9.47M 0.02% 465
2018
Q4 		$3.27M Buy
+126,895
New +$2.14M 0.01% 790

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TD Asset Management's TAK Position: Q4 2021 in Review

TD Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 47,760 shares — an estimated $782K sold.

TD Asset Management first reported a position in TAK in Q4 2018 and held it in 12 quarters. The position peaked at $14.4M in Q4 2019. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • TD Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • TD Asset Management sold 47,760 Takeda Pharmaceutical shares in Q4 2021, an estimated $782K.
  • TD Asset Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 12 quarters.
  • TD Asset Management's Takeda Pharmaceutical position peaked at $14.4M in Q4 2019.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.